Browse Related Topics For:

Pharmaceutical Industry The United States Food and Drug Administration

293
Prescription Drugs
145
Generic Drugs
141
Biosimilars
124
Patents
113
Pharmaceutical Patents
106
Medical Devices
86
Off-Label Promotion
76
ANDA
74
BPCIA
71
Healthcare
71
Patent Litigation
69
Patent Infringement
67
FDCA
59
Biologics
59
Hatch-Waxman
53
First Amendment
50
Labeling
49
Popular
44
Off-Label Use
44
Sandoz
42
Amarin
42
Amgen
41
Draft Guidance
37
SCOTUS
34
Advertising
34
Sandoz v Amgen
33
FDA Approval
33
HHS
33
Preemption
32
Misbranding
30
Free Speech
30
Manufacturers
30
Medicare
28
Drug Compounding
28
Marketing
27
Affordable Care Act
27
Medicaid
27
Pharmacies
26
FTC
26
Preliminary Injunctions
25
Clinical Trials
24
Failure To Warn
23
Warning Labels
22
Commercial Speech
22
Health Care Providers
21
CMS
21
Life Sciences
20
False Claims Act (FCA)
18
DOJ
18
Product Labels
17
Drug Safety
17
Social Media
16
Appeals
16
Biologics Price Competition and Innovation Act of 2009
16
Biotechnology
16
Physicians
15
Apotex
15
Caronia
15
Orphan Drugs
14
Safe Harbors
13
Enforcement Actions
13
Hospitals
13
Patent Dance
12
Comment Period
12
Commercial Marketing
12
DSCSA
12
Medical Research
12
NIH
12
PHRMA
12
Reverse Payment Settlement Agreements
12
Summary Judgment
11
Antitrust Litigation
11
Citizen Petitions
11
Corporate Counsel
11
DQSA
11
FFDCA
11
FTC v Actavis
11
GlaxoSmithKline
11
Johnson & Johnson
11
New Guidance
11
Notice Requirements
11
OIG
11
Proposed Regulation
11
Public Health Service Act
11
Settlement
10
AbbVie
10
aBLA
10
Healthcare Reform
10
Legislative Agendas
10
Professional Conferences
10
Social Networks
9
21st Century Cures Initiative
9
3D Printing
9
Declaratory Judgments
9
Discovery
9
Drug Pricing
9
False Advertising
9
PLIVA v Mensing
9
Proposed Legislation
9
SEC
9
Supply Chain
9
USPTO
8
Bayer
8
EU
8
Medicare Part D
8
Multidistrict Litigation
8
Mylan Pharmaceuticals
8
Patent Applications
8
Pending Legislation
8
Qui Tam
8
Section 340B
8
Teva Pharmaceuticals
8
Warning Letters
8
Whistleblowers
7
CDC
7
Civil Monetary Penalty
7
Criminal Prosecution
7
Enforcement
7
Final Guidance
7
Fraud
7
Hospira
7
HRSA
7
Misleading Statements
7
Orange Book
7
Otsuka Pharmaceutical
7
Patent-in-Suit
7
Personal Jurisdiction
7
Prior Art
7
Research and Development
7
Side Effects
7
Trademarks
6
Abbott Laboratories
6
Actavis Inc.
6
Birth Defects
6
Class Action
6
Compliance
6
Cybersecurity
6
DEA
6
Design Defects
6
Drug Approvals
6
Drug Distribution
6
FDA Warning Letters
6
GAO
6
Health Insurance
6
Janssen Pharmaceuticals
6
Pay-For-Delay
6
Public Comment
6
Reporting Requirements
6
World Health Organization
5
Administrative Procedure Act
5
Adverse Events
5
Allergan Inc
5
Cancer
5
Celebrity Endorsements
5
CHIP
5
Exclusivity
5
Federal Rule 12(b)(6)
5
HIPAA
5
Illegal Drugs
5
Infringement
5
Injunctive Relief
5
Innovation
5
Inter Partes Review Proceedings
5
IRS
5
Medicare Part B
5
Medtronic
5
Merck
5
Obviousness
5
Patient Safety
5
Personalized Medicine
5
Pfizer
5
PHSA
5
Product Exclusivity
5
Product Hopping
5
Standing
5
Unfair Competition
5
USDA
5
Watson Pharmaceuticals
4
Advisory Committee
4
Anti-Kickback Statute
4
Big Data
4
Biogen Idec
4
Black Box Warnings
4
Brand
4
Claim Construction
4
Classen Immunotherapies
4
Congressional Investigations & Hearings
4
Controlled Substances Act
4
Data Protection
4
Diagnostic Tests
4
Dietary Supplements
4
Disclosure Requirements
4
DNA
4
Durable Medical Equipment
4
EHR
4
EPA
4
Expert Testimony
4
FOIA
4
Health Information Technologies
4
Home Health Care
4
Informed Consent
4
Intellectual Property Protection
4
Kim Kardashian
4
Learned Intermediary
4
Legislative Committees
4
Licenses
4
Motion to Dismiss
4
Negligence
4
No-AG Agreement
4
OMB
4
OPDP
4
OxyContin
4
PDUFA
4
Pregnancy
4
Premarket Approval Applications
4
Public Meetings
4
Regulatory Agenda
4
Regulatory Standards
4
REMS
4
Scientific Research
4
Shareholders
4
UAW
4
Unfair or Deceptive Trade Practices
3
510(k) RTA
3
America Invents Act
3
Biopharmaceutical
3
Burden of Proof
3
CGMP
3
Chevron Deference
3
China
3
Competition
3
Databases
3
Daubert Standards
3
Declaratory Relief
3
Disgorgement
3
Elan Pharmaceuticals
3
Eli Lilly
3
Exclusive Dealing Agreements
3
False Statements
3
FCPA
3
FDASIA
3
Federal Register
3
Federal Rules of Civil Procedure
3
Fifth Amendment
3
Final Rules
3
Financial Conduct Authority (FCA)
3
Foreign Manufacturers
3
Generic
3
Genzyme
3
Google
3
Healthcare Facilities
3
Healthcare Fraud
3
Inadequate Warning
3
Insider Trading
3
Intellectual Property Litigation
3
Internet
3
Jurisdiction
3
Kickbacks
3
Lanham Act
3
License Agreements
3
Misleading Impressions
3
Mobile Apps
3
Mutual Pharmaceuticals v Bartlett
3
Novartis
3
openFDA
3
Outsourcing
3
Pain Management
3
Patent Invalidity
3
Patients
3
Prescription Drug Coverage
3
Private Right of Action
3
Product Recalls
3
Public Disclosure
3
Purple Book
3
Putative Class Actions
3
Risk Management
3
Rule-of-Reason Analysis
3
Samsung
3
Sealed Records
3
Secretary of HHS
3
Settlement Agreements
3
Sherman Act
3
Software
3
Strategic Enforcement Plan
3
Technology
3
Trade Secrets
3
Twitter
3
Veterinary Products
3
Websites
3
Wyeth
2
ACOs
2
Allergan v Sandoz
2
American Medical Association
2
Amicus Briefs
2
AMP v Myriad
2
Animal Testing
2
Anti-Competitive
2
Antibiotics
2
Antitrust Injuries
2
Antitrust Provisions
2
Antitrust Violations
2
Article III
2
AstraZeneca
2
Attorney-Client Privilege
2
Bifurcation
2
Boehringer
2
Bristol-Myers Squibb
2
Canada
2
Causation
2
Center for Drug Evaluation and Research (CDER)
2
CEOs
2
Certiorari
2
Chemicals
2
Class Certification
2
Clear and Convincing Evidence
2
Clinical Laboratory Testing
2
Combination Products
2
Contraceptives
2
Controlled Substances
2
Conversion
2
Counterclaims
2
Counterfeit Drugs
2
Covered Entities
2
DaimlerChrysler v Bauman
2
Data Integrity
2
Data Security
2
Disclaimers
2
Dismissals
2
Diversity Jurisdiction
2
DMEPOS
2
Drug & Alcohol Abuse
2
Due Process
2
Duty to Deal
2
Electronic Communications
2
Electronic Records
2
Endo Pharmaceuticals
2
Ethics
2
Evidence
2
Expert Witness
2
Federal Funding
2
Federal Health Care Programs (FHCP)
2
Federal Question Jurisdiction
2
First Impression
2
First-to-File
2
Food Labeling
2
Food Recalls
2
Fraudulent Joinder
2
FSMA
2
GDUFA
2
Genetic Testing
2
Gilead Sciences
2
Good Clinical Practices
2
Government Investigations
2
GPOs
2
Guidance Update
2
Hackers
2
Health Safety
2
HITECH
2
Imports
2
Induced Infringement
2
Injunctions
2
Innovator Liability
2
Inpatient Prospective Payment System (IPPS)
2
Inspections
2
Insurance Industry
2
Internal Controls
2
Internet Marketing
2
Interstate Commerce
2
Investigational New Drug Application (IND)
2
Investors
2
IP License
2
IRB
2
Licensing Rules
2
Long Term Care Facilities
2
Manufacturing Defects
2
Marijuana
2
Medicaid Expansion
2
Medical Device Accessories
2
Medical Malpractice
2
Medical Reimbursement
2
MedPAC
2
Mensing
2
Misrepresentation
2
Monopolization
2
Mootness
2
Native American Issues
2
Nike
2
Notice Provisions
2
Omnibus Guidance
2
Omnicare
2
On-Sale Bar
2
Online Advertisements
2
Patent Trial and Appeal Board
2
Patent-Eligible Subject Matter
2
Pay-Per-Click
2
Permanent Injunctions
2
POM Wonderful
2
Post-Grant Review
2
Presidential Elections
2
Product Defects
2
Public Health
2
Public Health Insurance Marketplace
2
RanBaxy
2
Recordkeeping Requirements
2
Reimbursements
2
Relators
2
Reverse Payments
2
Ripeness
2
Risk Assessment
2
Rulemaking Process
2
Search Engines
2
Section 503
2
Securities Fraud
2
Securities Litigation
2
Skilled Nursing Facility
2
SNDAs
2
Spectrum
2
Stark Law
2
Stem cells
2
Strict Liability
2
Subject Matter Jurisdiction
2
Substance Abuse
2
Sunshine Act
2
Takeda Pharmaceuticals
2
Tax Credits
2
Tax Deductions
2
Telemedicine
2
Television Commercials
2
Transparency
2
TRO
2
Two-Midnight Rule
2
User-Generated Content
2
Venture Capital
2
Verification Requirements
2
Warner Chilcott
2
Wholesale
2
Written Descriptions
2
Wrongful Death
1
35 U.S.C. § 271(e)(1)
1
Acceleration
1
Accounting Controls
1
Acquisitions
1
Actual Injuries
1
Additive Manufacturing
1
Admissible Evidence
1
Advance Notice
1
Advisory Opinions
1
Aerospace
1
AHRQ
1
AIDS
1
AIG
1
All Natural
1
Alzheimer's
1
Amazon
1
Amended Complaints
1
Amended Regulation
1
Amgen Inc. v Connecticut Retirement Plans
1
Animal Food
1
Animal Health
1
Antimicrobials
1
Antitrust Conspiracies
1
App Developers
1
Applicable Manufacturers
1
Applications
1
Appropriate Equitable Relief
1
Arbitration
1
Asbestos
1
Asbestos Litigation
1
Assignments
1
Attestation Deadlines
1
Attorney Generals
1
Audits
1
Automobile Recall
1
Automotive Industry
1
Bank of New York (BNY) Mellon
1
Banking Sector
1
Barack Obama
1
Barclays
1
Bayh-Dole Act
1
Best Management Practices
1
Best Practices
1
Billing
1
Bilski
1
Biometric Information
1
Bipolar Disorder
1
Boston Scientific
1
BPCI
1
Breakthrough Therapy Designation
1
Business Development
1
CA Supreme Court
1
CAFC
1
Canadian Intellectual Property Office
1
Cartwright Act
1
Carve Out Provisions
1
Caterpillar
1
CCIIO
1
Cephalon
1
CERCLA
1
Chief Compliance Officers
1
Childrens' Motrin
1
Chilling Effect
1
Chip and PIN
1
Cipro
1
Citizen Suits
1
Claim Preclusion
1
Clean Air Act
1
Clean Water Act
1
clear
1
Clearance
1
Climate Action Plan
1
Clinical Laboratories
1
CLS Bank v Alice Corp
1
Co-payments
1
Coca Cola
1
Commerce Clause
1
Community Health Systems
1
Compensatory Awards
1
Compensatory Damages
1
Competitive Bidding
1
Complete Genomics
1
Comptroller of the Treasury v Wynne
1
Confidential Documents
1
Confidential Information
1
Consent Decrees
1
Consumer Product Safety Commission (CPSC)
1
Consumer Protection Act
1
Contamination
1
Contests & Promotions
1
Continuing Medical Education
1
Contraceptive Coverage Mandate
1
Contract Drafting
1
Contributory Infringement
1
Corporate Integrity Agreement
1
Corporate Taxes
1
Corrective Actions
1
Corruption
1
Cost-Sharing
1
Counterfeiting
1
Covenant Not to Sue
1
Covered Business Method Patents
1
Covered Recipients
1
CPUC
1
CREATE Act
1
Credibility
1
Cross-Border Transactions
1
Crowdfunding
1
Cruel & Unusual Punishment
1
Customs and Border Protection
1
CVM
1
Cyber Attacks
1
Daiichi Sankyo
1
DaimlerAG
1
Data Breach
1
Data Controller
1
Data Mining
1
De Novo Standard of Review
1
Debit and Credit Card Transactions
1
Deceptive Intent
1
Defect
1
Defense Strategies
1
Delaware General Corporation Law
1
Delays
1
Department of Transportation (DOT)
1
Department of Veterans Affairs
1
Device Classification
1
DHS
1
Diagnostic Imaging Services
1
Diagnostic Method
1
Direct Purchasers
1
Disability Discrimination
1
Disclosure
1
Discounts
1
Discussion Draft
1
Dispute Resolution
1
Disruptive Technology
1
Distributors
1
Document Retention Policies
1
Donald Trump
1
Double Jeopardy
1
Drug Testing
1
DSHEA
1
Duty to Warn
1
E-Filing
1
EAR
1
EEOC
1
Eighth Amendment
1
Electronic Filing
1
Electronic Health Record Incentives
1
Electronically Stored Information
1
Eleventh Amendment
1
Email
1
Emerging Markets
1
Employer Mandates
1
En Banc Review
1
Environmental Policies
1
Ernst & Young
1
EU-US Privacy Shield
1
European Food Safety Authority (EFSA)
1
Events
1
Ex Post Facto Clause
1
Excise Tax
1
Executive Orders
1
Exemptions
1
Failure To Disclose
1
Failure To State A Claim
1
Fair Notice
1
False Press Release
1
Falsified Documents
1
Fast Track Process
1
FBI
1
FCC
1
FD&C Act
1
FDAMA
1
Federal Budget
1
Federal Rule 12(b)(1)
1
Federal v State Law Application
1
FedEx
1
Fee-for-Service
1
Fee-Shifting
1
Fiduciary Duty
1
Financial Institutions
1
Financial Markets
1
Flame Retardant
1
FMCSA
1
Foreign Corporations
1
Foreign Earned Income
1
Foreign Tax
1
Foreseeability
1
Forum Shopping
1
FSMB
1
FTC Act
1
Funding
1
General Electric
1
General Jurisdiction
1
General Wellness Devices
1
Genetic Materials
1
Goldman Sachs
1
Goodyear
1
Government Service Administration (GSA)
1
Grable Factors
1
gTLD
1
Hazardous Substances
1
Hazardous Waste
1
HCPCS
1
Health Insurance Exchanges
1
Health IT
1
Healthcare Costs
1
HELP
1
Hewlett-Packard
1
HIV
1
Hoffman LaRoche
1
Home Depot
1
Honeybees
1
Hospice
1
Human Genome Project
1
Human Rights
1
ICD-10
1
Implied Certification
1
In-Person Exam
1
Incentives
1
Income Taxes
1
Information Reports
1
Information Sharing
1
Initial Public Offerings
1
Inpatient Rehab Facilities
1
Integra
1
Inter Partes Reexamination
1
InterDigital Communications v ITC
1
Interest Rate Adjustments
1
Interest Rates
1
InterMune
1
International Arbitration
1
International Harmonization
1
Internet Retailers
1
INTERPOL
1
Interpretive Rule
1
Inventors
1
Investigational New Drug procedures (IND)
1
Investment Trust Companies
1
IRF Claim Processing
1
JAMA
1
Joinder
1
Joint Venture
1
Judicial Review
1
Jury Awards
1
Jury Trial
1
Justiciable Controversy
1
King v Burwell
1
KPMG
1
LabMD
1
Laboratory Developed Tests
1
Law Enforcement
1
Leave to Amend
1
Legal History
1
Legal Perspectives
1
Lipitor
1
Litigation Hold
1
Litigation Privilege
1
MA Supreme Court
1
Managed Care Contracts
1
Manufacturing Facilities
1
Marijuana Cultivation
1
Marijuana Related Businesses
1
Market Research
1
MasterCard
1
MCOs
1
Medical Foods
1
Medical Liability
1
Medical Supplies
1
Medicare Access and CHIP Reauthorization (MACRA)
1
Medicare Advantage
1
Memorandum of Understanding
1
Mental Health Initiatives
1
Mergers
1
Methane
1
Method Claims
1
Minor Children
1
Motion for Reconsideration
1
Motion To Centralize
1
Motion to Remand
1
Motion To Stay
1
Motor Carriers
1
NAD
1
NAFTA
1
Nanomedicine
1
Nanotechnology
1
National Cancer Moonshot
1
Natural Products
1
Negligence Per Se
1
Negligent Design
1
New Legislation
1
New Trial
1
Non-Practicing Entities
1
Non-Public Information
1
Notice of Appeal
1
Notifications
1
NPRM
1
Nursing Homes
1
Obama Administration
1
OECD
1
OEHHA
1
Office of Scientific Investigations (OSI)
1
OFVM
1
Oil & Gas
1
Omnicare v Laborers District Council
1
ONC
1
Online Platforms
1
Online Reviews
1
Open Enrollment
1
Opioid
1
OPPS
1
Opt-Outs
1
Out-of-State Companies
1
Outsourcing Facilities
1
Over-the-Counter Sales
1
Overpayment
1
Par Pharmaceutical
1
Parallel Claims
1
Partnerships
1
PATENT Act
1
Patent Cooperation Treaty
1
Patent Exhaustion
1
Patent Filings
1
Patent Portfolios
1
Patent Reform
1
Patent Term Extensions
1
Patent-Misuse
1
Patient Assistance Programs
1
Patient Privacy Rights
1
Patient Prospective Payment System
1
Patient-Specific
1
Pay or Play
1
Payment Records
1
PCORI
1
Pediatrics
1
Pension Funds
1
Personal Care Products
1
Personally Identifiable Information
1
Pesticides
1
Petition for Writ of Certiorari
1
Pharmaceutical Distribution
1
Pharmacist
1
PHI
1
Planned Parenthood
1
Pleading Standards
1
Policies and Procedures
1
POM Wonderful v Coca Cola
1
Pradaxa
1
Price Transparency
1
Primary Jurisdiction Doctrine
1
Prior User
1
Prioritized Examination
1
Prison
1
Privacy Laws
1
Privacy Policy
1
Privilege Logs
1
Product Enhancements
1
Professional Liability
1
Profits
1
Prometheus
1
PSLRA
1
Psychiatric Hospitals
1
PTAC
1
Public Notice
1
Public Performance Rights
1
Publicly-Traded Companies
1
Quality Control Plan
1
RCRA
1
Rebates
1
Reed v Town of Gilbert
1
Registration
1
Registration Requirement
1
Regulatory Reform
1
Release of Information
1
Remand
1
Reorganizations
1
Required Documentation
1
Research Funding
1
Restitution
1
Restraining Orders
1
Retailers
1
Retaliation
1
Reversal
1
Right to Try
1
Risk Mitigation
1
Risk-Based Approaches
1
Rule 26
1
Safety Precautions
1
Safety Standards
1
Sanctions
1
Sanofi-Aventis
1
SC Supreme Court
1
Schering-Plough
1
Scientific Evidence
1
Scope of Discovery Requests
1
Securities
1
Securities Act of 1933
1
Securities Exchange Act
1
Senate Judiciary Committee
1
Sham Litigation Exception
1
Shareholder Litigation
1
SmithKline Beecham
1
Social Security Act
1
Sovereign Immunity
1
Sovereign Wealth Funds
1
Special 301
1
Specialty Healthcare
1
Specific Jurisdiction
1
Split of Authority
1
Sponsors
1
SPVs
1
Standard of Review
1
Startups
1
State Budgets
1
State Health Insurance Exchanges
1
State Law Tort Claims
1
Statement of Opinion
1
Statute of Limitations
1
Subject Matter Experts
1
Subsidies
1
Supervision and Collaboration Agreements
1
Suppliers
1
Surveillance
1
Swaps
1
Tariffs
1
Tax Code
1
Tax Liability
1
Tax Returns
1
Technical Conference
1
Telehealth
1
Terms of Use
1
Testimony
1
The Common Rule
1
Third-Party
1
Tobacco Litigation
1
Tolling
1
Tortious Interference
1
Toxic Exposure
1
Toxic Substances Control Act (TSCA)
1
Trademark Searches
1
Transfer of Venue
1
Transvaginal Mesh
1
TRICARE
1
TRIPS Agreement
1
Trucking Industry
1
Twombly/Iqbal Pleading Standard
1
UK
1
Unclean Hands
1
Uniform Trade Secrets Acts
1
Universal Health Services Inc v United States ex rel Escobar
1
UPS
1
User Fees
1
Utility Patents
1
Vaccinations
1
Veterinarians
1
Viagra
1
Visa Inc
1
Vouchers
1
Wage and Hour
1
Waivers
1
Warranties
1
Waste
1
Waters of the United States
1
Webinars
1
Wellness Programs
1
Wells Fargo
1
Whistleblower Protection Policies
1
WIPO
1
Withdrawal
1
Work Plans
1
Work Product Privilege
1
Work-Product Doctrine
1
Workplace Safety
1
Written Consent
1
WTO
1
Yahoo!
1
Young Lawyers
1
YouTube
1
Zika